Tissue engineering for lateral ridge augmentation with recombinant human bone morphogenetic protein 2 combination therapy: a case report.
Identifieur interne : 005D99 ( PubMed/Checkpoint ); précédent : 005D98; suivant : 005E00Tissue engineering for lateral ridge augmentation with recombinant human bone morphogenetic protein 2 combination therapy: a case report.
Auteurs : George A. Mandelaris ; Daniel B. Spagnoli ; Alan L. Rosenfeld ; James Mckee ; Mei LuSource :
- The International journal of periodontics & restorative dentistry [ 1945-3388 ]
Descripteurs français
- KwdFr :
- Association thérapeutique, Facteur de croissance transformant bêta (usage thérapeutique), Filet chirurgical, Humains, Implants dentaires, Ingénierie tissulaire, Jeune adulte, Mâchoire partiellement édentée (rééducation et réadaptation), Mâle, Pose d'implant dentaire endo-osseux (), Protéine morphogénétique osseuse de type 2 (usage thérapeutique), Protéines recombinantes (usage thérapeutique), Reconstruction de crête alvéolaire (), Transplantation osseuse.
- MESH :
- rééducation et réadaptation : Mâchoire partiellement édentée.
- usage thérapeutique : Facteur de croissance transformant bêta, Protéine morphogénétique osseuse de type 2, Protéines recombinantes.
- Association thérapeutique, Filet chirurgical, Humains, Implants dentaires, Ingénierie tissulaire, Jeune adulte, Mâle, Pose d'implant dentaire endo-osseux, Reconstruction de crête alvéolaire, Transplantation osseuse.
English descriptors
- KwdEn :
- Alveolar Ridge Augmentation (methods), Bone Morphogenetic Protein 2 (therapeutic use), Bone Transplantation, Combined Modality Therapy, Dental Implantation, Endosseous (methods), Dental Implants, Humans, Jaw, Edentulous, Partially (rehabilitation), Male, Recombinant Proteins (therapeutic use), Surgical Mesh, Tissue Engineering, Transforming Growth Factor beta (therapeutic use), Young Adult.
- MESH :
- chemical , therapeutic use : Bone Morphogenetic Protein 2, Recombinant Proteins, Transforming Growth Factor beta.
- methods : Alveolar Ridge Augmentation, Dental Implantation, Endosseous.
- rehabilitation : Jaw, Edentulous, Partially.
- Bone Transplantation, Combined Modality Therapy, Dental Implants, Humans, Male, Surgical Mesh, Tissue Engineering, Young Adult.
Abstract
This case report describes a tissue-engineered reconstruction with recombinant human bone morphogenetic protein 2/acellular collagen sponge (rhBMP-2/ ACS) + cancellous allograft and space maintenance via Medpor Contain mesh in the treatment of a patient requiring maxillary and mandibular horizontal ridge augmentation to enable implant placement. The patient underwent a previously unsuccessful corticocancellous bone graft at these sites. Multiple and contiguous sites in the maxilla and in the mandibular anterior, demonstrating advanced lateral ridge deficiencies, were managed using a tissue engineering approach as an alternative to autogenous bone harvesting. Four maxillary and three mandibular implants were placed 9 and 10 months, respectively, after tissue engineering reconstruction, and all were functioning successfully after 24 months of follow-up. Histomorphometric analysis of a bone core obtained at the time of the maxillary implant placement demonstrated a mean of 76.1% new vital bone formation, 22.2% marrow/cells, and 1.7% residual graft tissue. Tissue engineering for lateral ridge augmentation with combination therapy requires further research to determine predictability and limitations.
PubMed: 25909520
Affiliations:
Links toward previous steps (curation, corpus...)
Links to Exploration step
pubmed:25909520Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Tissue engineering for lateral ridge augmentation with recombinant human bone morphogenetic protein 2 combination therapy: a case report.</title><author><name sortKey="Mandelaris, George A" sort="Mandelaris, George A" uniqKey="Mandelaris G" first="George A" last="Mandelaris">George A. Mandelaris</name></author><author><name sortKey="Spagnoli, Daniel B" sort="Spagnoli, Daniel B" uniqKey="Spagnoli D" first="Daniel B" last="Spagnoli">Daniel B. Spagnoli</name></author><author><name sortKey="Rosenfeld, Alan L" sort="Rosenfeld, Alan L" uniqKey="Rosenfeld A" first="Alan L" last="Rosenfeld">Alan L. Rosenfeld</name></author><author><name sortKey="Mckee, James" sort="Mckee, James" uniqKey="Mckee J" first="James" last="Mckee">James Mckee</name></author><author><name sortKey="Lu, Mei" sort="Lu, Mei" uniqKey="Lu M" first="Mei" last="Lu">Mei Lu</name></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="????"><PubDate><MedlineDate>2015 May-Jun</MedlineDate></PubDate></date><idno type="RBID">pubmed:25909520</idno><idno type="pmid">25909520</idno><idno type="wicri:Area/PubMed/Corpus">000443</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000443</idno><idno type="wicri:Area/PubMed/Curation">000443</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">000443</idno><idno type="wicri:Area/PubMed/Checkpoint">000443</idno><idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">000443</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Tissue engineering for lateral ridge augmentation with recombinant human bone morphogenetic protein 2 combination therapy: a case report.</title><author><name sortKey="Mandelaris, George A" sort="Mandelaris, George A" uniqKey="Mandelaris G" first="George A" last="Mandelaris">George A. Mandelaris</name></author><author><name sortKey="Spagnoli, Daniel B" sort="Spagnoli, Daniel B" uniqKey="Spagnoli D" first="Daniel B" last="Spagnoli">Daniel B. Spagnoli</name></author><author><name sortKey="Rosenfeld, Alan L" sort="Rosenfeld, Alan L" uniqKey="Rosenfeld A" first="Alan L" last="Rosenfeld">Alan L. Rosenfeld</name></author><author><name sortKey="Mckee, James" sort="Mckee, James" uniqKey="Mckee J" first="James" last="Mckee">James Mckee</name></author><author><name sortKey="Lu, Mei" sort="Lu, Mei" uniqKey="Lu M" first="Mei" last="Lu">Mei Lu</name></author></analytic><series><title level="j">The International journal of periodontics & restorative dentistry</title><idno type="eISSN">1945-3388</idno></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Alveolar Ridge Augmentation (methods)</term><term>Bone Morphogenetic Protein 2 (therapeutic use)</term><term>Bone Transplantation</term><term>Combined Modality Therapy</term><term>Dental Implantation, Endosseous (methods)</term><term>Dental Implants</term><term>Humans</term><term>Jaw, Edentulous, Partially (rehabilitation)</term><term>Male</term><term>Recombinant Proteins (therapeutic use)</term><term>Surgical Mesh</term><term>Tissue Engineering</term><term>Transforming Growth Factor beta (therapeutic use)</term><term>Young Adult</term></keywords><keywords scheme="KwdFr" xml:lang="fr"><term>Association thérapeutique</term><term>Facteur de croissance transformant bêta (usage thérapeutique)</term><term>Filet chirurgical</term><term>Humains</term><term>Implants dentaires</term><term>Ingénierie tissulaire</term><term>Jeune adulte</term><term>Mâchoire partiellement édentée (rééducation et réadaptation)</term><term>Mâle</term><term>Pose d'implant dentaire endo-osseux ()</term><term>Protéine morphogénétique osseuse de type 2 (usage thérapeutique)</term><term>Protéines recombinantes (usage thérapeutique)</term><term>Reconstruction de crête alvéolaire ()</term><term>Transplantation osseuse</term></keywords><keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en"><term>Bone Morphogenetic Protein 2</term><term>Recombinant Proteins</term><term>Transforming Growth Factor beta</term></keywords><keywords scheme="MESH" qualifier="methods" xml:lang="en"><term>Alveolar Ridge Augmentation</term><term>Dental Implantation, Endosseous</term></keywords><keywords scheme="MESH" qualifier="rehabilitation" xml:lang="en"><term>Jaw, Edentulous, Partially</term></keywords><keywords scheme="MESH" qualifier="rééducation et réadaptation" xml:lang="fr"><term>Mâchoire partiellement édentée</term></keywords><keywords scheme="MESH" qualifier="usage thérapeutique" xml:lang="fr"><term>Facteur de croissance transformant bêta</term><term>Protéine morphogénétique osseuse de type 2</term><term>Protéines recombinantes</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Bone Transplantation</term><term>Combined Modality Therapy</term><term>Dental Implants</term><term>Humans</term><term>Male</term><term>Surgical Mesh</term><term>Tissue Engineering</term><term>Young Adult</term></keywords><keywords scheme="MESH" xml:lang="fr"><term>Association thérapeutique</term><term>Filet chirurgical</term><term>Humains</term><term>Implants dentaires</term><term>Ingénierie tissulaire</term><term>Jeune adulte</term><term>Mâle</term><term>Pose d'implant dentaire endo-osseux</term><term>Reconstruction de crête alvéolaire</term><term>Transplantation osseuse</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">This case report describes a tissue-engineered reconstruction with recombinant human bone morphogenetic protein 2/acellular collagen sponge (rhBMP-2/ ACS) + cancellous allograft and space maintenance via Medpor Contain mesh in the treatment of a patient requiring maxillary and mandibular horizontal ridge augmentation to enable implant placement. The patient underwent a previously unsuccessful corticocancellous bone graft at these sites. Multiple and contiguous sites in the maxilla and in the mandibular anterior, demonstrating advanced lateral ridge deficiencies, were managed using a tissue engineering approach as an alternative to autogenous bone harvesting. Four maxillary and three mandibular implants were placed 9 and 10 months, respectively, after tissue engineering reconstruction, and all were functioning successfully after 24 months of follow-up. Histomorphometric analysis of a bone core obtained at the time of the maxillary implant placement demonstrated a mean of 76.1% new vital bone formation, 22.2% marrow/cells, and 1.7% residual graft tissue. Tissue engineering for lateral ridge augmentation with combination therapy requires further research to determine predictability and limitations.</div></front></TEI><pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">25909520</PMID><DateCompleted><Year>2017</Year><Month>01</Month><Day>17</Day></DateCompleted><DateRevised><Year>2017</Year><Month>01</Month><Day>17</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1945-3388</ISSN><JournalIssue CitedMedium="Internet"><Volume>35</Volume><Issue>3</Issue><PubDate><MedlineDate>2015 May-Jun</MedlineDate></PubDate></JournalIssue><Title>The International journal of periodontics & restorative dentistry</Title><ISOAbbreviation>Int J Periodontics Restorative Dent</ISOAbbreviation></Journal><ArticleTitle>Tissue engineering for lateral ridge augmentation with recombinant human bone morphogenetic protein 2 combination therapy: a case report.</ArticleTitle><Pagination><MedlinePgn>325-33</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.11607/prd.2378</ELocationID><Abstract><AbstractText>This case report describes a tissue-engineered reconstruction with recombinant human bone morphogenetic protein 2/acellular collagen sponge (rhBMP-2/ ACS) + cancellous allograft and space maintenance via Medpor Contain mesh in the treatment of a patient requiring maxillary and mandibular horizontal ridge augmentation to enable implant placement. The patient underwent a previously unsuccessful corticocancellous bone graft at these sites. Multiple and contiguous sites in the maxilla and in the mandibular anterior, demonstrating advanced lateral ridge deficiencies, were managed using a tissue engineering approach as an alternative to autogenous bone harvesting. Four maxillary and three mandibular implants were placed 9 and 10 months, respectively, after tissue engineering reconstruction, and all were functioning successfully after 24 months of follow-up. Histomorphometric analysis of a bone core obtained at the time of the maxillary implant placement demonstrated a mean of 76.1% new vital bone formation, 22.2% marrow/cells, and 1.7% residual graft tissue. Tissue engineering for lateral ridge augmentation with combination therapy requires further research to determine predictability and limitations.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Mandelaris</LastName><ForeName>George A</ForeName><Initials>GA</Initials></Author><Author ValidYN="Y"><LastName>Spagnoli</LastName><ForeName>Daniel B</ForeName><Initials>DB</Initials></Author><Author ValidYN="Y"><LastName>Rosenfeld</LastName><ForeName>Alan L</ForeName><Initials>AL</Initials></Author><Author ValidYN="Y"><LastName>McKee</LastName><ForeName>James</ForeName><Initials>J</Initials></Author><Author ValidYN="Y"><LastName>Lu</LastName><ForeName>Mei</ForeName><Initials>M</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D002363">Case Reports</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Int J Periodontics Restorative Dent</MedlineTA><NlmUniqueID>8200894</NlmUniqueID><ISSNLinking>0198-7569</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D055396">Bone Morphogenetic Protein 2</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D015921">Dental Implants</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D011994">Recombinant Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D016212">Transforming Growth Factor beta</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C499469">recombinant human bone morphogenetic protein-2</NameOfSubstance></Chemical></ChemicalList><CitationSubset>D</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000540" MajorTopicYN="N">Alveolar Ridge Augmentation</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D055396" MajorTopicYN="N">Bone Morphogenetic Protein 2</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016025" MajorTopicYN="N">Bone Transplantation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003131" MajorTopicYN="N">Combined Modality Therapy</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003758" MajorTopicYN="N">Dental Implantation, Endosseous</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015921" MajorTopicYN="Y">Dental Implants</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007576" MajorTopicYN="N">Jaw, Edentulous, Partially</DescriptorName><QualifierName UI="Q000534" MajorTopicYN="N">rehabilitation</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011994" MajorTopicYN="N">Recombinant Proteins</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013526" MajorTopicYN="N">Surgical Mesh</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D023822" MajorTopicYN="Y">Tissue Engineering</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016212" MajorTopicYN="N">Transforming Growth Factor beta</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2015</Year><Month>4</Month><Day>25</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2015</Year><Month>4</Month><Day>25</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2017</Year><Month>1</Month><Day>18</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">25909520</ArticleId></ArticleIdList></PubmedData></pubmed><affiliations><list></list><tree><noCountry><name sortKey="Lu, Mei" sort="Lu, Mei" uniqKey="Lu M" first="Mei" last="Lu">Mei Lu</name><name sortKey="Mandelaris, George A" sort="Mandelaris, George A" uniqKey="Mandelaris G" first="George A" last="Mandelaris">George A. Mandelaris</name><name sortKey="Mckee, James" sort="Mckee, James" uniqKey="Mckee J" first="James" last="Mckee">James Mckee</name><name sortKey="Rosenfeld, Alan L" sort="Rosenfeld, Alan L" uniqKey="Rosenfeld A" first="Alan L" last="Rosenfeld">Alan L. Rosenfeld</name><name sortKey="Spagnoli, Daniel B" sort="Spagnoli, Daniel B" uniqKey="Spagnoli D" first="Daniel B" last="Spagnoli">Daniel B. Spagnoli</name></noCountry></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/EdenteV2/Data/PubMed/Checkpoint
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 005D99 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd -nk 005D99 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Santé
|area= EdenteV2
|flux= PubMed
|étape= Checkpoint
|type= RBID
|clé= pubmed:25909520
|texte= Tissue engineering for lateral ridge augmentation with recombinant human bone morphogenetic protein 2 combination therapy: a case report.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/RBID.i -Sk "pubmed:25909520" \
| HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd \
| NlmPubMed2Wicri -a EdenteV2
| This area was generated with Dilib version V0.6.32. |  |